Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Gemcitabine Combinations vs Cisplatin/Gemcitabine Followed by Docetaxel in Advanced NSCLC
NCT00425191Phase 2Completed
- Sponsor
- Sanofi
- Start
- Jul 2002
- Primary completion
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel in non-small cell lung cancer (NSCLC), sponsored by Sanofi. Started Jul 2002; status: completed.
02
Drugs
docetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00425191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425191.